1 Liao MT, "Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy" 128 : e600-e604, 2011
2 Lai KN, "The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia" 54 : 12-17, 1990
3 Yi Z, "The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis" 10 : 165-173, 2011
4 Zheng XY, "Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis" 18 : 821-832, 2012
5 Lai KN, "Membranous nephropathy related to hepatitis B virus in adults" 324 : 1457-1463, 1991
6 Bhimma R, "Hepatitis B virus-associated nephropathy" 24 : 198-211, 2004
7 선인오, "Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains" 대한내과학회 27 (27): 411-416, 2012
8 Shin SK, "Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B" 18 : 550-559, 1999
9 Chang TT, "A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B" 354 : 1001-1010, 2006
10 Ebata S, "A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler’s disease" 16 : 805-810, 2012